ID návrhu | Typ návrhu | Stav návrhu | ATC | ŠÚKL- kód lieku | Príznak | Konanie začaté od | Navrhovateľ | Akcia |
---|---|---|---|---|---|---|---|---|
1 2 3 4 5 > >> | ||||||||
27860 | A3 | Podaný | A10BD07 | 76788 | ![]() |
3.2.2023 | Merck Sharp & Dohme B.V. | Detaily |
27858 | A3 | Podaný | N06DA02, N05AX12 ![]() |
47797, 2645D ![]() |
![]() |
3.2.2023 | Vipharm S.A. | Detaily |
27859 | A3 | Podaný | V01AA02, V01AA05 | 28409, 28203 | ![]() |
3.2.2023 | Allergy Therapeutics Ibérica, S.L.U. | Detaily |
27857 | A3 | Podaný | A02BC01 | 0908B | ![]() |
3.2.2023 | Neuraxpharm Bohemia s.r.o. | Detaily |
27856 | A3 | Podaný | G03GA05 | 0256B | ![]() |
3.2.2023 | Gedeon Richter Plc. | Detaily |
27855 | A3 | Podaný | N06AB05, J01MA01 ![]() |
37101, 37099 ![]() |
![]() |
2.2.2023 | Medochemie LTD | Detaily |
27853 | A3 | Podaný | B01AC06 | 6826C | ![]() |
2.2.2023 | Medreg s.r.o. | Detaily |
27844 | A3 | Podaný | R03DX07 | 21490 | ![]() |
1.2.2023 | AstraZeneca AB | Detaily |
27843 | KON | Podaný | L04AC05 | 87598 | ![]() |
1.2.2023 | Ministerstvo zdravotníctva | Detaily |
27842 | KON | Podaný | L04AC05 | 87598 | ![]() |
1.2.2023 | Ministerstvo zdravotníctva | Detaily |
27841 | A3 | Podaný | J07BB03 | 6372B | ![]() |
1.2.2023 | AstraZeneca AB | Detaily |
27767 | A3 | Podaný | A10BJ06 | 8854C | ![]() |
1.2.2023 | Novo Nordisk A/S | Detaily |
27835 | A3 | Podaný | J07AJ52 | 45368 | ![]() |
1.2.2023 | GlaxoSmithKline Biologicals S.A. | Detaily |
27834 | A3 | Podaný | J07CA02 | 45411 | ![]() |
1.2.2023 | GlaxoSmithKline Biologicals S.A. | Detaily |
27831 | A3 | Podaný | N06AB10 | 68676 | ![]() |
1.2.2023 | TEVA Pharmaceuticals Slovakia s.r.o. | Detaily |
27832 | A3 | Podaný | J06BA02 | 50935 | ![]() |
1.2.2023 | CSL Behring GmbH | Detaily |
27705 | A3 | Podaný | L04AD01, R01AD08 | 10185, 10184 ![]() |
![]() |
1.2.2023 | Teva Czech Industries s.r.o. | Detaily |
27808 | A3 | Podaný | C09AA04, C09BB04 ![]() |
8870D, 8866D ![]() |
![]() |
1.2.2023 | KRKA, d.d., Novo mesto | Detaily |
27807 | H3 | Podaný | L04AA25 | 43567 | ![]() |
31.1.2023 | AstraZeneca AB | Detaily |
27830 | A3 | Podaný | A10BB09, C09BB04 ![]() |
82651, 4214B ![]() |
![]() |
31.1.2023 | ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. | Detaily |
27829 | CND | Podaný | L01EX01 | 7973D | ![]() |
31.1.2023 | Glenmark Pharmaceuticals s.r.o. | Detaily |
27828 | H3 | Podaný | C07AB05 | 27057 | ![]() |
31.1.2023 | CHEPLAPHARM Arzneimittel GmbH | Detaily |
27827 | H3 | Podaný | D07AB02 | 09310 | ![]() |
31.1.2023 | CHEPLAPHARM Arzneimittel GmbH | Detaily |
27826 | H3 | Podaný | C02CA06 | 90765 | ![]() |
31.1.2023 | CHEPLAPHARM Arzneimittel GmbH | Detaily |
27825 | H3 | Podaný | C02CA06 | 90763 | ![]() |
31.1.2023 | CHEPLAPHARM Arzneimittel GmbH | Detaily |